Nkarta, Inc.

NKTX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.2B · 108 employees
101
SEC Filings
$2.92
Close 2026-09-04
108
Employees

Business Summary

Nkarta, Inc. is a clinical-stage biopharmaceutical company developing allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. Its lead program, NKX019, is a CAR NK product candidate targeting CD19 for autoimmune diseases including lupus nephritis, systemic sclerosis, myositis, and ANCA-associated vasculitis. NKX019 is being studied in Phase 1 trials (Ntrust-1, Ntrust-2) and investigator-sponsored trials. The company operates cGMP manufacturing facilities in South San Francisco, California.

Latest Stock Quote

NKTX 2026-09-04 $2.92 O:$2.77 H:$2.93 L:$2.75 Vol:0.4M VWAP:$2.8752
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-13

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-252025-12-310001787400-26-000006EDGAR89K words
2025-03-262024-12-310000950170-25-045262EDGAR87K words
2024-03-212023-12-310000950170-24-034735EDGAR92K words
2023-03-162022-12-310000950170-23-008523EDGAR85K words
2022-03-172021-12-310000950170-22-004095EDGAR—
2021-03-252020-12-310001564590-21-015517EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-102026-06-300001787400-26-000017EDGAR64K words
2025-11-102025-09-300001193125-25-274304EDGAR64K words
2025-08-122025-06-300001193125-25-178964EDGAR62K words
2025-05-142025-03-310000950170-25-071455EDGAR60K words
2024-11-072024-09-300000950170-24-123395EDGAR62K words
2024-08-132024-06-300000950170-24-096186EDGAR62K words
2024-05-092024-03-310000950170-24-056980EDGAR61K words
2023-11-092023-09-300000950170-23-062091EDGAR60K words
2023-08-102023-06-300000950170-23-040953EDGAR59K words
2023-05-112023-03-310000950170-23-021277EDGAR56K words
2022-11-092022-09-300000950170-22-023845EDGAR—
2022-08-112022-06-300000950170-22-016892EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-100001193125-26-342402EDGAR2K words
2026-03-260001787400-26-000008EDGAR1K words
2026-03-250001787400-26-000005EDGAR2K words
2025-11-100001193125-25-274261EDGAR2K words
2025-08-120001193125-25-178949EDGAR2K words
2025-06-060000950170-25-082717EDGAR1K words
2025-05-140000950170-25-071399EDGAR2K words
2025-03-260000950170-25-045231EDGAR3K words
2024-11-070000950170-24-123340EDGAR2K words
2024-08-130000950170-24-096163EDGAR2K words

101 total filings indexed. 73 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

autoimmune-diseases b-cell-hematologic-malignancies cell-therapy cgmp-(current-good-manufacturing-practice)

Company Identity

CIK0001787400
TickerNKTX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
HeadquartersSouth San Francisco, California
Websitehttps://www.nkartatx.com
Listed2020-07-10

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 9d02694872794f38f62d1a2a78170720985aa2f37f770a84e22a630f5d01a296
parent: 6c6264b7959ed6ea2f8fe8e427e72b27616253faa3aacd5c5bd1b118c461162b
content hash: 1d03e6d1cded29f676720a5783cc037429d4c52beae3c007fa1c6e607b2109d6
signed: 2026-09-29T12:02:26.505Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up NKTX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on NKTX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/NKTX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.